Systematic review compares functional outcomes of mothership and drip-and-ship strategies in acute ischemic stroke, suggesting better outcomes with mothership.
Background and aims The optimal prehospital referral strategy for patients with acute ischemic stroke due to large vessel occlusion (AIS-LVO) remains controversial. This systematic review and meta-analysis compared the clinical outcomes of mothership versus drip-and-ship strategies (Fig. 1). Methods A systematic review of PubMed, Embase, Web of Science, and the Cochrane Library from inception to November 2025 identified studies comparing mothership and drip-and-ship strategies in AIS-LVO patients undergoing mechanical thrombectomy (Fig. 2). Random-effects meta-analyses were performed to estimate pooled odds ratios (ORs) for primary efficacy outcomes, including 90-day mRS 0–2, 90-day mRS 0–3, and successful recanalization. Safety outcomes included symptomatic intracranial hemorrhage (sICH) and 90-day all-cause mortality. Results A total of 42 cohort studies comprising 25,005 patients were included. The mothership strategy was associated with a 15% increased likelihood of achieving 90-day mRS 0–2 (OR 1.15, 95%CI 1.03–1.29, I2=53%) (Fig. 3). However, no statistically significant between-group differences were observed for 90-day mRS 0–3 (OR: 1.12, 95% CI: 0.97–1.29; I2 = 52%), successful recanalization (OR: 1.03, 95% CI: 0.90–1.18; I2 = 60%), sICH (OR: 0.84, 95% CI: 0.69–1.02; I2 = 22%), and 90-day mortality (OR: 0.99, 95% CI: 0.85–1.15; I2 = 60%). Conclusions The mothership strategy was associated with better 90-day functional independence (mRS 0–2) compared with drip-and-ship, while no significant differences were found for 90-day mRS 0–3, successful recanalization, sICH, or 90-day mortality (PROSPERO ID: CRD420251000352). Conflict of interest This study was supported by the Chengdu Medical Research Project (Grant No. 2025435). Lei Guo: nothing to disclose; Guo Tang: nothing to disclose; Yang Xiang: nothing to disclose; Quan Li: nothing to disclose; Chunling Li: nothing to disclose; Shu Yang: nothing to disclose; Neng-Wei Yu: nothing to disclose; Fu-Qiang Guo: nothing to disclose; Jun Zhang: nothing to disclose. Figure 1 - belongs to Background and aims Figure 2 - belongs to Methods Table 1 - belongs to Results
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: